Dr. George E. Anastassov, Director, for CanChew Biotechnologies, a Company that MJNA holds a 50% stake in, called into SmallCapVoice.com to go over thier revolutionary new products. CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. Recently MJNA announced that Canipa Holdings is currently working with European Health Authorities and their Governmental counterparts to obtain marketing approvals for the Dixie X and CanChew gum hemp-based, CBD-infused products. We expect preliminary approval in 60 days and final approval 30 days after. Once approved, these products will be sold “over-the-counter” throughout Romania and the remaining 26 European Union Member Countries.

medicalmarijuanainc.com
canchewbiotech.com